DE10350425A1 - Viscous shower oil - Google Patents
Viscous shower oil Download PDFInfo
- Publication number
- DE10350425A1 DE10350425A1 DE2003150425 DE10350425A DE10350425A1 DE 10350425 A1 DE10350425 A1 DE 10350425A1 DE 2003150425 DE2003150425 DE 2003150425 DE 10350425 A DE10350425 A DE 10350425A DE 10350425 A1 DE10350425 A1 DE 10350425A1
- Authority
- DE
- Germany
- Prior art keywords
- oil
- hydrocarbon
- carbon atoms
- preparation
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000002360 preparation method Methods 0.000 claims abstract description 59
- 239000003921 oil Substances 0.000 claims abstract description 37
- 239000004215 Carbon black (E152) Substances 0.000 claims abstract description 24
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 24
- 229930195733 hydrocarbon Natural products 0.000 claims abstract description 24
- 150000002430 hydrocarbons Chemical class 0.000 claims abstract description 24
- 239000004094 surface-active agent Substances 0.000 claims abstract description 21
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000003349 gelling agent Substances 0.000 claims abstract description 17
- 239000004952 Polyamide Substances 0.000 claims abstract description 15
- 229920002647 polyamide Polymers 0.000 claims abstract description 15
- 239000002537 cosmetic Substances 0.000 claims abstract description 13
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 9
- 239000001301 oxygen Substances 0.000 claims abstract description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 8
- 125000005842 heteroatom Chemical group 0.000 claims abstract description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 6
- 235000019198 oils Nutrition 0.000 claims description 36
- -1 hydroxyalkyl ammonium salts Chemical class 0.000 claims description 16
- 239000000284 extract Substances 0.000 claims description 8
- 238000004140 cleaning Methods 0.000 claims description 7
- 230000005540 biological transmission Effects 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 5
- 244000144927 Aloe barbadensis Species 0.000 claims description 4
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 4
- 235000011399 aloe vera Nutrition 0.000 claims description 4
- 239000008163 avocado oil Substances 0.000 claims description 4
- 235000021302 avocado oil Nutrition 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 239000001944 prunus armeniaca kernel oil Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 239000010497 wheat germ oil Substances 0.000 claims description 4
- 241001474374 Blennius Species 0.000 claims description 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 3
- 229930195729 fatty acid Natural products 0.000 claims description 3
- 239000000194 fatty acid Substances 0.000 claims description 3
- 235000019489 Almond oil Nutrition 0.000 claims description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 2
- 244000060011 Cocos nucifera Species 0.000 claims description 2
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 2
- 241000208680 Hamamelis mollis Species 0.000 claims description 2
- 229920002884 Laureth 4 Polymers 0.000 claims description 2
- 235000019493 Macadamia oil Nutrition 0.000 claims description 2
- 240000000982 Malva neglecta Species 0.000 claims description 2
- 235000000060 Malva neglecta Nutrition 0.000 claims description 2
- 244000042664 Matricaria chamomilla Species 0.000 claims description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 2
- 235000019483 Peanut oil Nutrition 0.000 claims description 2
- 229920001363 Polidocanol Polymers 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 2
- 235000019486 Sunflower oil Nutrition 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 239000008168 almond oil Substances 0.000 claims description 2
- 239000004359 castor oil Substances 0.000 claims description 2
- 235000019438 castor oil Nutrition 0.000 claims description 2
- 239000003240 coconut oil Substances 0.000 claims description 2
- 235000019864 coconut oil Nutrition 0.000 claims description 2
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 claims description 2
- 235000008524 evening primrose extract Nutrition 0.000 claims description 2
- 239000010475 evening primrose oil Substances 0.000 claims description 2
- 229940089020 evening primrose oil Drugs 0.000 claims description 2
- 150000004665 fatty acids Chemical class 0.000 claims description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 2
- 229940061515 laureth-4 Drugs 0.000 claims description 2
- 239000010469 macadamia oil Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 239000002480 mineral oil Substances 0.000 claims description 2
- 235000010446 mineral oil Nutrition 0.000 claims description 2
- 239000011570 nicotinamide Substances 0.000 claims description 2
- 229960003966 nicotinamide Drugs 0.000 claims description 2
- 235000005152 nicotinamide Nutrition 0.000 claims description 2
- 229940101267 panthenol Drugs 0.000 claims description 2
- 239000011619 pantothenol Substances 0.000 claims description 2
- 235000020957 pantothenol Nutrition 0.000 claims description 2
- 239000000312 peanut oil Substances 0.000 claims description 2
- 239000000419 plant extract Substances 0.000 claims description 2
- ONJQDTZCDSESIW-UHFFFAOYSA-N polidocanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO ONJQDTZCDSESIW-UHFFFAOYSA-N 0.000 claims description 2
- 229960002226 polidocanol Drugs 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 239000003549 soybean oil Substances 0.000 claims description 2
- 235000012424 soybean oil Nutrition 0.000 claims description 2
- 239000002600 sunflower oil Substances 0.000 claims description 2
- 229940118846 witch hazel Drugs 0.000 claims description 2
- 235000019774 Rice Bran oil Nutrition 0.000 claims 1
- 235000019485 Safflower oil Nutrition 0.000 claims 1
- 150000002191 fatty alcohols Chemical class 0.000 claims 1
- 239000008165 rice bran oil Substances 0.000 claims 1
- 235000005713 safflower oil Nutrition 0.000 claims 1
- 239000003813 safflower oil Substances 0.000 claims 1
- 238000002834 transmittance Methods 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 239000003963 antioxidant agent Substances 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 7
- 239000000975 dye Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000005238 degreasing Methods 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 125000003835 nucleoside group Chemical group 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- IZFHEQBZOYJLPK-SSDOTTSWSA-N (R)-dihydrolipoic acid Chemical compound OC(=O)CCCC[C@@H](S)CCS IZFHEQBZOYJLPK-SSDOTTSWSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WCOXQTXVACYMLM-UHFFFAOYSA-N 2,3-bis(12-hydroxyoctadecanoyloxy)propyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC(O)CCCCCC)COC(=O)CCCCCCCCCCC(O)CCCCCC WCOXQTXVACYMLM-UHFFFAOYSA-N 0.000 description 1
- RJFAYQIBOAGBLC-UHFFFAOYSA-N 2-amino-4-methylselanyl-butanoic acid Chemical compound C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ODJQKYXPKWQWNK-UHFFFAOYSA-N 3,3'-Thiobispropanoic acid Chemical compound OC(=O)CCSCCC(O)=O ODJQKYXPKWQWNK-UHFFFAOYSA-N 0.000 description 1
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 description 1
- GWXXFGWOWOJEEX-UHFFFAOYSA-N 4,4,4-trihydroxy-1-phenylbutan-1-one Chemical compound OC(CCC(=O)C1=CC=CC=C1)(O)O GWXXFGWOWOJEEX-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 108010085443 Anserine Proteins 0.000 description 1
- XHVAWZZCDCWGBK-WYRLRVFGSA-M Aurothioglucose Chemical compound OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O XHVAWZZCDCWGBK-WYRLRVFGSA-M 0.000 description 1
- GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 description 1
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 0 CCC(C)(C(*)=O)N(*)*N(*)C(C)=O Chemical compound CCC(C)(C(*)=O)N(*)*N(*)C(C)=O 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- GHKOFFNLGXMVNJ-UHFFFAOYSA-N Didodecyl thiobispropanoate Chemical compound CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC GHKOFFNLGXMVNJ-UHFFFAOYSA-N 0.000 description 1
- 239000003508 Dilauryl thiodipropionate Substances 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 239000002656 Distearyl thiodipropionate Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- SLRNWACWRVGMKD-UHFFFAOYSA-N L-anserine Natural products CN1C=NC(CC(NC(=O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-UHFFFAOYSA-N 0.000 description 1
- 150000000998 L-ascorbyl palmitates Chemical class 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 241000210053 Potentilla elegans Species 0.000 description 1
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 1
- 241000350481 Pterogyne nitens Species 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- ARCJQKUWGAZPFX-KBPBESRZSA-N S-trans-stilbene oxide Chemical compound C1([C@H]2[C@@H](O2)C=2C=CC=CC=2)=CC=CC=C1 ARCJQKUWGAZPFX-KBPBESRZSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- WPMWEFXCIYCJSA-UHFFFAOYSA-N Tetraethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCO WPMWEFXCIYCJSA-UHFFFAOYSA-N 0.000 description 1
- 239000003490 Thiodipropionic acid Substances 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- MYYIAHXIVFADCU-QMMMGPOBSA-N anserine Chemical compound CN1C=NC=C1C[C@H](NC(=O)CC[NH3+])C([O-])=O MYYIAHXIVFADCU-QMMMGPOBSA-N 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 229960001799 aurothioglucose Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 125000001743 benzylic group Chemical group 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000000973 cosmetic coloring agent Substances 0.000 description 1
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 1
- 229940099500 cystamine Drugs 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000019304 dilauryl thiodipropionate Nutrition 0.000 description 1
- PWWSSIYVTQUJQQ-UHFFFAOYSA-N distearyl thiodipropionate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCCCCCCCC PWWSSIYVTQUJQQ-UHFFFAOYSA-N 0.000 description 1
- 235000019305 distearyl thiodipropionate Nutrition 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 125000005908 glyceryl ester group Chemical group 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000004021 humic acid Substances 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- HCZKYJDFEPMADG-TXEJJXNPSA-N masoprocol Chemical compound C([C@H](C)[C@H](C)CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-TXEJJXNPSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- SQGMBDQWNFMOIU-UHFFFAOYSA-N propane-1,1,1-triol;propane-1,2,3-triol Chemical compound CCC(O)(O)O.OCC(O)CO SQGMBDQWNFMOIU-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960002662 propylthiouracil Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000004170 rice bran wax Substances 0.000 description 1
- 235000019384 rice bran wax Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- ARCJQKUWGAZPFX-UHFFFAOYSA-N stilbene oxide Chemical compound O1C(C=2C=CC=CC=2)C1C1=CC=CC=C1 ARCJQKUWGAZPFX-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 150000001629 stilbenes Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 125000005555 sulfoximide group Chemical group 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000008646 thermal stress Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 235000019303 thiodipropionic acid Nutrition 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940040064 ubiquinol Drugs 0.000 description 1
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/88—Polyamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
Kosmetische
Reinigungszubereitung, enthaltend
a) einen oder mehrere modifizierte
Polyamid-Gelbildner, welche die folgende Struktur aufweisen:
R1 = Kohlenwasserstoff mit 1-22 Kohlenstoffatomen,
R2 = Kohlenwasserstoff mit 2-42 Kohlenstoffatomen,
R3 = Kohlenwasserstoff mit 2-36 Kohlenstoffatomen,
enthaltend 0-3 Heteroatome, gewählt
aus der Gruppe Sauerstoff und Stickstoff,
R3a
= H, C1-C10-Kohlenstoffrest,
in
einer Konzentration von 0,2 bis 10 Gewichts-%,
b) ein oder mehrere öllösliche Tenside
in einer Gesamtkonzentration von 5 bis 50 Gewichts-%,
c) ein
oder mehrere Öle
in einer Gesamtkonzentration von 10 bis 95 Gewichts-%,
d) bis
zu 1 Gewichts-% Wasser,
jeweils bezogen auf das Gesamtgewicht
der Zubereitung,
mit einer Viskosität von 300 bis 4000 mPa.s und
einer Transmission von 30 bis 100% bei 550 nm.Cosmetic cleansing preparation containing
a) one or more modified polyamide gelling agents which have the following structure:
R 1 = hydrocarbon with 1-22 carbon atoms,
R 2 = hydrocarbon with 2-42 carbon atoms,
R 3 = hydrocarbon having 2-36 carbon atoms containing 0-3 heteroatoms selected from the group of oxygen and nitrogen,
R 3 a = H, C 1 -C 10 -carbon radical,
in a concentration of 0.2 to 10% by weight,
b) one or more oil-soluble surfactants in a total concentration of 5 to 50% by weight,
c) one or more oils in a total concentration of 10 to 95% by weight,
d) up to 1% by weight of water,
in each case based on the total weight of the preparation,
with a viscosity of 300 to 4000 mPa.s and a transmittance of 30 to 100% at 550 nm.
Description
Die vorliegende Erfindung betrifft den Einsatz modifizierter Polyamid-Gelbildner in kosmetischen Zubereitungen.The The present invention relates to the use of modified polyamide gelling agents in cosmetic preparations.
Der Wunsch nach sauberer Haut ist wohl so alt wie die Menschheit, denn Schmutz, Schweiß und Reste abgestorbener Hautpartikel bieten den idealen Nährboden für Krankheitserreger und Parasiten aller Art. Die Lust an der Körperhygiene wurde stetig verstärkt, als in den 60er Jahren des 20. Jahrhunderts neben der „klassischen" Seife auch flüssige Reinigungsmittel mit neu entwickelten synthetischen Tensiden formuliert werden konnten. Baden und Duschen sind seitdem aus unserem täglichen Leben nicht mehr wegzudenken. Den Verbrauchern stehen heutzutage eine Vielzahl von Produkten für die Reinigung der verschiedenen Körperpartien zur Verfügung.Of the Desire for clean skin is probably as old as humanity, because Dirt, sweat and Remnants of dead skin particles provide the ideal breeding ground for pathogens and parasites of all kinds. The desire for personal hygiene has been steadily increasing when in the 60s of the 20th century in addition to the "classic" soap and liquid detergents could be formulated with newly developed synthetic surfactants. Since then, bathing and showering have become indispensable in our daily lives. Consumers today have a variety of products for cleaning the different body parts to Available.
Bei einer Reinigung der Haut mit Hilfe von Wasser (insbesondere in Verbindung mit Tensiden) kommt es zunächst zu einer Quellung der Hornschicht der Haut. Der Grad dieser Quellung hängt u. a. von der Dauer des Bades und dessen Temperatur ab. Gleichzeitig werden wasserlösliche Stoffe ab- bzw. ausgewaschen, wie z. B. wasserlösliche Schmutzbestandteile, aber auch hauteigene Stoffe, die für das Wasserbindungsvermögen der Hornschicht verantwortlich sind. Durch hauteigene oberflächenaktive Stoffe werden außerdem auch Hautfette in gewissem Ausmaß gelöst und ausgewaschen. Dies bedingt nach anfänglicher Quellung eine nachfolgende Austrocknung der Haut.at a cleaning of the skin with the help of water (especially in conjunction with surfactants) comes first to a swelling of the horny layer of the skin. The degree of this swelling depends u. a. from the duration of the bath and its temperature. simultaneously become water-soluble Cloths washed or washed out, such as. B. water-soluble soil constituents, but also the skin's own substances, which are responsible for the water-binding capacity of the Horn layer are responsible. By the skin's own surface-active Fabrics will also Skin fats also dissolved and washed out to a certain extent. This conditionally after initial Swelling a subsequent dehydration of the skin.
Waschaktive Tenside, welche die Haut und Haare von fettigen und wasserlöslichen Schmutzbestandteilen reinigen sollen, haben auch eine entfettende Wirkung auf die normalen Hautlipide. Bei jeder Hautreinigung werden in unterschiedlichem Maß auch interkorneozytäre Lipide und Sebumbestandteile entfernt. Das bedeutet, dass der natürliche Wasser-Lipid-Mantel der Haut bei jedem Waschvorgang mehr oder weniger gestört wird. Dies kann besonders bei extremer Entfettung zu einer kurzzeitigen Veränderung der Barrierefunktion der Haut führen, wobei selbstverständlich auch der jeweilige Zustand der behandelten Hautregion auf die dargestellten Veränderungen von erheblichem Einfluss ist.Detergent Active Surfactants containing the skin and hair of greasy and water-soluble To clean dirt particles, also have a degreasing Effect on the normal skin lipids. Be at every skin cleansing to varying degrees, too interkorneozytäre Lipids and sebum components removed. That means the natural water-lipid coat The skin is more or less disturbed during each wash. This can be a short-term, especially in extreme degreasing change lead to the barrier function of the skin, of course also the respective condition of the treated skin region on the illustrated changes is of considerable influence.
Beispielsweise kann die Hautdicke, die Anzahl der Talg- und Schweißdrüsen sowie die damit verbundene Empfindlichkeit erheblich variieren.For example can skin thickness, the number of sebaceous and sweat glands as well the associated sensitivity varies considerably.
Es
hat deshalb nicht an Versuchen gefehlt, geeignete Reinigungszubereitungen
zu finden, welche die Haut bei guter Reinigungsleistung gleichzeitig
regenerieren bzw. „rückfetten". Eine besondere
Gruppe an Hautreinigungsprodukten bilden dabei die Duschöle. Duschöle enthalten
als Hauptbestandteile Öle
und in der Ölphase
lösliche
Tenside. Ein Beispiel für
Duschöle
ist in der
Die Herstellung von Duschölen ist technisch jedoch äußerst schwierig, da es nur mit ausgewählten Ölen und Tensiden gelingt, stabile, halbwegs transparente oder zumindest transluzente einphasige Duschöle herzustellen.The Production of shower oils is technically very difficult as it is only with selected oils and Surfactants succeed, stable, reasonably transparent or at least produce translucent single-phase shower oils.
Ein wesentlicher Nachteil herkömmlicher Duschöle besteht nun in dem Umstand, dass diese äußerst dünnflüssig sind. Nach dem Stand der Technik lassen sich nur Duschöle mit einer Viskosität von etwa 180 mPaS (gemessen auf Ares 5 bei einer Scherrate von 10 s–1, 25°C, Alu.-Platte-Kege1:0,1 radians) stabil herstellen. Dünnflüssige Duschöle haben jedoch den Nachteil, dass sie schwer auf die Haut aufzutragen sind, da sie sehr aus der Hand oder vom Körper herunter fließen. Viele Anwender klagen darüber, ihnen würde das Duschöl „wie Wasser durch die Finger rinnen".A major disadvantage of conventional shower oils is the fact that they are extremely thin. According to the state of the art, only shower oils having a viscosity of about 180 mPaS (measured on Ares 5 at a shear rate of 10 s -1 , 25 ° C., aluminum plate Kege 1: 0.1 radians) can be produced stably. However, thin-bodied shower oils have the disadvantage that they are difficult to apply to the skin, as they flow very much from the hand or from the body down. Many users complain that the shower oil "runs through them like water".
Nun mag es dem Laien zur Lösung dieses Problems zunächst als Nahe liegend erscheinen, dem Duschöl ein Verdickungsmittel zuzusetzen, um ein höher viskoses Duschöl zu erhalten. Der (kosmetischen) Fachwelt ist es jedoch bisher noch nicht gelungen, ein für tensidhaltige Duschöle geeignetes Verdickungsmittel zu finden. Zahlreiche Versuche mit einer Vielzahl von Verdickungsmitteln wie Transgel 105, Transgel 110, Transgel 510, Thixcin R, Aminofect, Versage) M750 oder Reiskleiewachs schlugen fehl, da es in den Zubereitungen zu Phasentrennungen, Trübungen und Ausfällungen kam. Auch wurde häufig eine zu hohe Viskosität (d.h. ein „fest werden") der Zubereitung beobachtet: Nicht zuletzt ließen die Produkte in Anwendungstests ein stumpfes Hautgefühl bei den Probanden zurück.Now likes it to the layman to the solution this problem first appear close to add a thickener to the shower oil, one higher viscous shower oil to obtain. The (cosmetic) experts, however, it is still failed to get one for surfactant-containing shower oils to find suitable thickening agent. Numerous experiments with a variety of thickeners such as Transgel 105, transgel 110, Transgel 510, Thixcin R, Aminofect, failure) M750 or rice bran wax failed because it in the preparations to phase separations, cloudiness and precipitations came. Also became common too high a viscosity (i.e. a "stuck be ") of the preparation observed: Last but not least the products in application tests a dull skin feeling in the Subjects back.
Es war daher die Aufgabe der vorliegenden Erfindung, ein verdicktes Duschöl zu entwickeln, dass eine Viskosität von mindestens 300 mPa-s aufweist, transparent ist und auch bei längerer Lagerung oder thermischer Beanspruchung stabil und einphasig bleibt.It Therefore, the object of the present invention, a thickened shower oil to develop a viscosity of at least 300 mPa-s has, is transparent and even with prolonged storage or thermal Stress remains stable and single-phase.
Ferner war es die Aufgabe der vorliegenden Erfindung, ein Verdickungsmittel zur Verdickung von kosmetischen Duschölen zu finden.Further It was the object of the present invention to provide a thickener to find thickening of cosmetic shower oils.
Nicht zuletzt war es die Aufgabe der vorliegenden Erfindung, ein Duschöl mit angenehmen sensorischen Eigenschaften zu entwickeln.Not Lastly, it was the object of the present invention, a shower oil with pleasant develop sensory properties.
Überraschend werden die Aufgaben gelöst durch eine kosmetische Reinigungszubereitung enthaltend
- a) einen oder mehrere modifizierte Polyamid-Gelbildner, welche
die folgende Struktur aufweisen: mit n = 0–5 R1 = Kohlenwasserstoff mit 1–22 Kohlenstoffatomen, R2 = Kohlenwasserstoff mit 2–42 Kohlenstoffatomen, R3 = Kohlenwasserstoff mit 2–36 Kohlenstoffatomen, enthaltend 0–3 Heteroatome, gewählt aus der Gruppe Sauerstoff und Stickstoff, R3a = H, C1-C10-Kohlenstoffrest, in einer Konzentration von 0,2 bis 10 Gewichts-%,
- b) ein oder mehrere öllösliche Tenside in einer Gesamtkonzentration von 5 bis 50 Gewichts-%,
- c) ein oder mehrere Öle in einer Gesamtkonzentration von 10 bis 95 Gewichts-%,
- d) bis zu 1 Gewichts-% Wasser, jeweils bezogen auf das Gesamtgewicht der Zubereitung, mit einer Viskosität von 300 bis 4000 mPaS und einer Transmission von 30 bis 100% bei 550 nm Wellenlänge.
- a) one or more modified polyamide gelling agents which have the following structure: with n = 0-5 R 1 = hydrocarbon having 1-22 carbon atoms, R 2 = hydrocarbon having 2-42 carbon atoms, R 3 = hydrocarbon having 2-36 carbon atoms, containing 0-3 heteroatoms selected from the group of oxygen and nitrogen, R 3 a = H, C 1 -C 10 -carbon radical, in a concentration of 0.2 to 10% by weight,
- b) one or more oil-soluble surfactants in a total concentration of 5 to 50% by weight,
- c) one or more oils in a total concentration of 10 to 95% by weight,
- d) up to 1% by weight of water, in each case based on the total weight of the preparation, having a viscosity of from 300 to 4000 mPaS and a transmission of from 30 to 100% at a wavelength of 550 nm.
Dabei weist die erfindungsgemäße Zubereitung erfindungsgemäß vorteilhaft einen tan-Delta-Wert von bis und erfindungsgemäß bevorzugt einen tan-Delta-Wert von 0,25 bis 0,23 auf. Der tan Delta-wert wurde dabei erfindungsgemäß mit einem SR 2000 Gerät der Firma Rheoteric Scietific bei 0,1 rad/s, 40°C und einem Meßsystem: Platte/Platte 25 mm, 1 mm Abstand, bestimmt.there has the preparation according to the invention According to the invention advantageous a tan delta value from bis and inventively preferred a tan delta value of 0.25 to 0.23. The tan delta value was according to the invention with a SR 2000 device Rheoteric Scietific at 0.1 rad / s, 40 ° C and a measuring system: Plate / plate 25 mm, 1 mm distance, determined.
Modifizierte Polyamid-Gelbildner wurden bisher nach dem Stande der Technik zur Herstellung von Kerzen (US 2002/0068811) oder zur Herstellung von wässrigen Suspensionen (WO 03/050164) verwendet. Da derartige Zubereitungen fest bzw. wasserhaltig sind und darüber hinaus keine Tenside enthalten, konnten sie nicht den Weg zur vorliegenden Erfindung weisen. Vielmehr wäre für den Fachmann zu erwarten gewesen, dass sich mit modifizierten Polyamid-Gelbildnern keine flüssig-viskosen Zubereitungen herstellen lassen bzw. dass zur Erlangung akzeptabler Viskositäten ein Mindestgehalt an Wasser zwingend erforderlich sei.modified Polyamide gelling agents have hitherto been used in the art Production of candles (US 2002/0068811) or for the production of aqueous Suspensions (WO 03/050164) used. As such preparations are solid or hydrous and moreover contain no surfactants, they could not point the way to the present invention. Much more would be for the expert had been expected to deal with modified polyamide gelling agents no liquid-viscous Make preparations or that to obtain acceptable viscosities a minimum level of water is mandatory.
Die erfindungsgemäßen Zubereitungen führen beim Verbraucher nach er Anwendung zu einem fühlbar glatten, geschmeidigen und gepflegten Hautgefühl.The preparations according to the invention to lead at the consumer after he application to a palpably smooth, supple and well-groomed skin feeling.
Es
ist erfindungsgemäß bevorzugt,
wenn die erfindungsgemäße Zubereitung
einen oder mehrere modifizierte Polyamid-Gelbildner, welche die
folgende Struktur aufweisen:
R1 =
Kohlenwasserstoff mit 1–22
Kohlenstoffatomen,
R2 = Kohlenwasserstoff
mit 2–42
Kohlenstoffatomen,
R3 = Kohlenwasserstoff
mit 2–36
Kohlenstoffatomen, enthaltend 0–3
Heteroatome, gewählt
aus der Gruppe Sauerstoff und Stickstoff,
R3a
= H, C1-C10-Kohlenstoffrest,
in
einer Konzentration von 2 bis 3 Gewichts-%, bezogen auf das Gesamtgewicht
der Zubereitung enthalten.It is preferred according to the invention if the preparation according to the invention comprises one or more modified polyamide gelling agents which have the following structure:
R 1 = hydrocarbon with 1-22 carbon atoms,
R 2 = hydrocarbon with 2-42 carbon atoms,
R 3 = hydrocarbon having 2-36 carbon atoms containing 0-3 heteroatoms selected from the group of oxygen and nitrogen,
R 3 a = H, C 1 -C 10 -carbon radical,
in a concentration of 2 to 3% by weight, based on the total weight of the preparation.
Erfindungsgemäß bevorzugt enthält die erfindungsgemäße Zubereitung ein oder mehrere öllösliche Tenside in einer Gesamtkonzentration von 10 bis 30 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung.According to the invention preferred contains the preparation according to the invention one or more oil-soluble surfactants in a total concentration of 10 to 30% by weight, based on the total weight of the preparation.
Erfindungsgemäß bevorzugt enthält die erfindungsgemäße Zubereitung ein oder mehrere Öle in einer Gesamtkonzentration von 30 bis 70 Gewichts-% und besonders bevorzugt in einer Konzentration von 40 bis 60 Gewichts-%, jeweils bezogen auf das Gesamtgewicht der Zubereitung.According to the invention preferred contains the preparation according to the invention one or more oils in a total concentration of 30 to 70% by weight and especially preferably in a concentration of 40 to 60% by weight, respectively based on the total weight of the preparation.
Weiterhin bevorzugt sind erfindungsgemäße Zubereitungen, welche „wasserfrei" sind. Hierzu sind im Sinne der vorliegenden Erfindung auch solche Zubereitungen zu rechnen, denen kein Wasser zugesetzt wird, welche aber produktionsbedingt – beispielsweise durch Verwendung bestimmter wasserhaltiger Rohstoffe – geringe Mengen Wasser enthalten können.Farther preferred preparations according to the invention are which are "anhydrous" in the context of the present invention, also such preparations count, where no water is added, but which is production-related - for example by using certain hydrous raw materials - low May contain amounts of water.
Die erfindungsgemäße Viskosität wurde mit Hilfe eines Ares 5-Gerätes bei 25°C und einer Scherrate von 10 s–1 (Meßsystem: Alu.-Platte-Kegel, 0,1 radians) bestimmt. Dabei hat es sich als erfindungsgemäß bevorzugt erwiesen, wenn die Zubereitung eine Viskosität von 1500 bis 2700 mPaS aufwies.The viscosity according to the invention was determined using an Ares 5 apparatus at 25 ° C. and a shear rate of 10 s -1 (measuring system: aluminum plate cone, 0.1 radians). It has proved to be preferred according to the invention, if the preparation had a viscosity of 1500 to 2700 mPaS.
Die erfindungsgemäße Transmission wurde erfindungsgemäß mit dem Gerät Agilent 8453 Diode Arrag Spectrometer bei einer Schichtdicke von 1 cm bestimmt. Die Messung wurde in einem Bereich von 190 bis 1100 nm in Intervallen von 1 nm und einer Integrationszeit von 0,5 Sekunden bei Raumtemperatur durchgeführt. Erfindungsgemäß bevorzugt beträgt die Transmission der erfindungsgemäßen Zubereitung Transmission von 35 bis 85% bei 550 nm Wellenlänge. Erfindungsgemäß vorteilhafte öllösliche Tenside werden gewählt aus der Gruppe der Verbindungen der Alkyl- und/oder Hydroxyalkyl-Ammoniumsalze der Fettalkoholethersulfate. Dabei ist es erfindungsgemäß bevorzugt, wenn als öllösliche Tenside Monoisopropanolaminlaurylethersulfate (MIPA-Laureth Sulfate), Laureth-4 (CAS: 5274-68-0, Kokusfettsäurediethanolamid (Cocamide DEA) und/oder Triisopropanolaminlaurylethersulfate (TIPA-Laureth Sulfate) eingesetzt werden.The Transmission according to the invention Was inventively with the Device Agilent 8453 Diode Arrag Spectrometer determined at a layer thickness of 1 cm. The measurement was in a range of 190 to 1100 nm at intervals of 1 nm and an integration time of 0.5 seconds at room temperature carried out. According to the invention preferred is the transmission of the preparation of the invention transmission from 35 to 85% at 550 nm wavelength. According to the invention advantageous oil-soluble surfactants are chosen the group of compounds of alkyl and / or hydroxyalkyl ammonium salts the fatty alcohol ether sulfates. It is preferred according to the invention when as oil-soluble surfactants Monoisopropanolamine lauryl ether sulfates (MIPA-Laureth Sulfate), Laureth-4 (CAS: 5274-68-0, Coconut fatty acid diethanolamide (Cocamide DEA) and / or Triisopropanolaminlaurylethersulfate (TIPA Laureth Sulfates) are used.
Die Ölphase der erfindungsgemäßen Zubereitung kann neben Ölen erfindungsgemäß vorteilhaft auch Fette, Wachse und dergleichen enthalten, also Verbindungen, die der Fachmann auch als Lipide bezeichnet.The oil phase of inventive preparation can in addition to oils According to the invention advantageous also contain fats, waxes and the like, ie compounds, the specialist also referred to as lipids.
Die Ölphase der erfindungsgemäßen Zubereitungen wird vorteilhaft gewählt aus der Gruppe der unpolaren Lipide mit einer Polarität ≥ 30 mN/m. Besonders vorteilhafte unpolare Lipide im Sinne der vorliegenden Erfindung sind die im folgenden aufgelisteten.The oil phase of preparations according to the invention is chosen favorably from the group of nonpolar lipids with a polarity ≥ 30 mN / m. Particularly advantageous nonpolar lipids in the context of the present invention are listed below.
Als erfindungsgemäße Öle werden bevorzugt ein oder mehrere Öle gewählt aus der Gruppe Sojaöl, Rizinusöl, Sonnenblumenöl, Weizenkeimöl, Reisöl, Diestelöl, Erdnussöl, Kokosnussöl, Macadamiaöl, Mandelöl, Nachtkerzenöl, Mineralöl, eingesetzt.When Oils according to the invention are preferably one or more oils chosen from the group of soybean oil, castor oil, sunflower oil, wheat germ oil, rice oil, Diestelöl, peanut oil, coconut oil, macadamia oil, almond oil, evening primrose oil, mineral oil used.
Erfindungsgemäß vorteilhafte
Polyamid-Gelbildner sind in der US 2002/0068811 offenbart. Erfindungsgemäß bevorzugte
Ausführungsformen
der vorliegenden Erfindung sind dadurch gekennzeichnet, dass der
oder die Polyamid-Gelbildner als Strukturelement
Erfindungsgemäß bevorzugt wird der Baustein R2 aus einem C10-C22-Kohlenstoffrest gebildet.According to the invention, the building block R 2 is preferably formed from a C 10 -C 22 -carbon radical.
Ferner ist es erfindungsgemäß ganz besonders bevorzugt, wenn der Baustein R2 aus einer C16H32-Alkylkette gebildet wird.Furthermore, it is very particularly preferred according to the invention if the building block R 2 is formed from a C 16 H 32 -alkyl chain.
Erfindungsgemäß am meisten bevorzugt ist die am Tage der Prioritätsanmeldung unter dem Handelsnamen Sylvaclear A200V bei der Firma Arizona Chemical frei erhältliche Verbindung mit der INCI-Bezeichnung: Ethylenediamine/Hydrogenated Dimer Dilinoleate Copolymer Bis-Di-C14-18 Alkyl Amide.Most according to the invention preferred is the day of the priority application under the trade name Sylvaclear A200V freely available from Arizona Chemical Associated with the INCI name: Ethylenediamine / Hydrogenated Dimer Dilinoleate Copolymer Bis-Di-C14-18 Alkyl amides.
In vorteilhaften Ausführungsformen der vorliegenden Erfindung enthalten die erfindungsgemäßen Reinigungszubereitungen einen oder mehrere Wirkstoffe gewählt aus der Gruppe der pflanzlichen Wirkstoffe, pflanzliche Öle, Pflanzenextrakte und Vitamine wie insbesondere Kamille, Aloe Vera, Aprikosenkernöl, Avocadoöl, Aloe Vera, Aprikosenkernöl, Avocadoöl, Weizenkeimöl, Pflanzenextrakte wie Hamamelisextrakt, Malvenextrakt, Meeresalgenextrakt, Panthenol, Niacinamid, Polidocanol.In advantageous embodiments The present invention contains the cleaning preparations according to the invention one or more active ingredients selected from the group of vegetable Active ingredients, vegetable oils, Herbal extracts and vitamins such as chamomile, aloe vera, Apricot kernel oil, Avocado oil, Aloe vera, apricot kernel oil, Avocado oil, Wheat germ oil, Plant extracts such as witch hazel extract, mallow extract, seaweed extract, Panthenol, niacinamide, polidocanol.
Diese Wirkstoffe können erfindungsgemäß vorteilhaft in einer Gesamtkonzentration von 0,1 bis 1,0 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung eingesetzt werden.These Active ingredients can According to the invention advantageous in a total concentration of 0.1 to 1.0% by weight be used on the total weight of the preparation.
Wenn Zubereitungen gemäß der vorliegenden Erfindung außer den erfindungsgemäßen Tensiden weitere Tenside enthalten sollen, so wird bevorzugt, deren Konzentration in Bezug auf das Gewicht der Gesamtzusammensetzung nicht größer als 5 Gew.-% zu wählen.If Preparations according to the present invention Invention except the surfactants according to the invention further To contain surfactants, it is preferred that their concentration in terms of the weight of the total composition does not exceed 5 wt .-% to choose.
Erfindungsgemäß können als günstige Antioxidantien alle für kosmetische und/oder dermatologische Anwendungen geeigneten oder gebräuchlichen Antioxidantien verwendet werden.According to the invention can as favorable Antioxidants all for cosmetic and / or dermatological applications suitable or common Antioxidants are used.
Vorteilhaft
werden die Antioxidantien gewählt
aus der Gruppe
Aminosäuren
(z. B. Glycin, Histidin, Tyrosin, Tryptophan) und deren Derivate,
Imidazole (z. B. Urocaninsäure) und
deren Derivate, Peptide wie D,L-Carnosin, D-Carnosin, L-Carnosin
und deren Derivate (z. B. Anserin), Carotinoide, Carotine (z. B. α-Carotin, β-Carotin,
Lycopin) und deren Derivate, Liponsäure und deren Derivate (z. B.
Dihydroliponsäure),
Aurothioglucose, Propylthiouracil und andere Thiole (z. B. Thioredoxin,
Glutathion, Cystein, Cystin, Cystamin und deren Glycosyl-, N-Acetyl-,
Methyl-, Ethyl-, Propyl-, Amyl-, Butyl- und Lauryl-, Palmitoyl-,
Oleyl-, gamma-Linoleyl-, Cholesteryl- und Glycerylester) sowie deren
Salze, Dilaurylthiodipropionat, Distearylthiodipropionat, Thiodipropionsäure und
deren Derivate (Ester, Ether, Peptide, Lipide, Nukleotide, Nukleoside
und Salze) sowie Sulfoximinverbindungen (z. B. Buthioninsulfoximine,
Homocysteinsulfoximin, Buthioninsulfone, Pentat-, Hexa-, Heptahioninsulfoximin)
in sehr geringen verträglichen
Dosierungen (z. B. pmol bis μmol/kg),
ferner (Metall)-Chelatoren (z. B. α-Hydroxyfettsäuren, Palmitinsäure, Phytinsäure, Lactoferrin), α-Hydroxysäuren (z.
B. Zitronensäure,
Milchsäure,
Apfelsäure),
Huminsäure,
Gallensäure,
Gallenextrakte, Bilirubin, Biliverdin, EDTA, EGTA und deren Derivate,
ungesättigte
Fettsäuren
und deren Derivate (z. B. gamma-Linolensäure, Linolsäure, Ölsäure), Folsäure und deren Derivate, Ubiquinon
und Ubiquinol deren Derivate, Vitamin C und Derivate (z. B. Ascorbylpalmitate,
Mg – Ascorbylphosphate,
Ascorbylacetate), Tocopherole und Derivate (z. B. Vitamin E – acetat),
Vitamin A und Derivate (Vitamin A – palmitat) sowie Konyferylbenzoat
des Benzoeharzes, Rutinsäure
und deren Derivate, Ferulasäure
und deren Derivate, Butylhydroxytoluol, Butylhydroxyanisol, Nordihydroguajakharzsäure, Nordihydroguajaretsäure, Trihydroxybutyrophenon,
Harnsäure
und deren Derivate, Mannose und deren Derivate, Zink und dessen
Derivate (z. B. ZnO, ZnSO4) Selen und dessen Derivate
(z. B. Selenmethionin), Stilbene und deren Derivate (z. B. Stilbenoxid,
Trans-Stilbenoxid) und die erfindungsgemäß geeigneten Derivate (Salze,
Ester, Ether, Zucker, Nukleotide, Nukleoside, Peptide und Lipide) dieser
genannten Wirkstoffe.Advantageously, the antioxidants are selected from the group
Amino acids (eg glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (eg urocaninic acid) and their derivatives, peptides such as D, L-carnosine, D-carnosine, L-carnosine and their derivatives (eg B. anserine), carotenoids, carotenes (eg, α-carotene, β-carotene, lycopene) and their derivatives, lipoic acid and its derivatives (eg dihydrolipoic acid), aurothioglucose, propylthiouracil and other thiols (e.g. Thioredoxin, glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, gamma-linoleyl, cholesteryl and glyceryl esters) and their salts, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and derivatives thereof (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) and sulfoximine compounds (eg buthionine sulfoximines, homocysteinesulfoximine, buthionine sulfones, pentat, hexa, Heptahioninsulfoximin) in very low tolerated dosages (eg pmol to μmol / kg), furthermore (metal) chelators (e.g. Α-hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), α-hydroxy acids (e.g., citric acid, lactic acid, malic acid), humic acid, bile acid, bile extracts, bilirubin, biliverdin, EDTA, EGTA and their derivatives, unsaturated fatty acids and their derivatives (eg gamma-linolenic acid, linoleic acid, oleic acid), folic acid and its derivatives, ubiquinone and ubiquinol their derivatives, vitamin C and derivatives (eg ascorbyl palmitates, Mg ascorbyl phosphates, ascorbyl acetates), tocopherols and derivatives (e.g. Vitamin E - acetate), vitamin A and derivatives (vitamin A - palmitate) and benzylic resin, rutinic acid and its derivatives, ferulic acid and its derivatives, butylhydroxytoluene, butylated hydroxyanisole, nordihydroguaiacetic acid, nordihydroguiaretic acid, trihydroxybutyrophenone, uric acid and its derivatives, mannose and their derivatives Derivatives, zinc and its derivatives (eg ZnO, ZnSO 4 ) selenium and its derivatives (eg selenium methionine), stilbenes and their derivatives ivate (eg stilbene oxide, trans-stilbene oxide) and the derivatives suitable according to the invention (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of these active substances mentioned.
Besonders vorteilhaft im Sinne der vorliegenden Erfindung können öllösliche Antioxidantien eingesetzt werden.Especially For the purposes of the present invention, oil-soluble antioxidants may be advantageous be used.
Die Menge der Antioxidantien (eine oder mehrere Verbindungen) in den Zubereitungen beträgt vorzugsweise 0,001 bis 30 Gew.-%, besonders bevorzugt 0,05 bis 20 Gew.-%, insbesondere 0,1 bis 10 Gew.-%, bezogen auf das Gesamtgewicht der Zubereitung.The Amount of antioxidants (one or more compounds) in the Preparations is preferably from 0.001 to 30% by weight, particularly preferably from 0.05 to 20 Wt .-%, in particular 0.1 to 10 wt .-%, based on the total weight the preparation.
Sofern Vitamin E und/oder dessen Derivate das oder die Antioxidantien darstellen, ist vorteilhaft, deren jeweilige Konzentrationen aus dem Bereich von 0,001 bis 10 Gew.-%, bezogen auf das Gesamtgewicht der Formulierung, zu wählen.Provided Vitamin E and / or derivatives thereof are the antioxidant (s), is advantageous, their respective concentrations from the field from 0.001 to 10% by weight, based on the total weight of the formulation, to choose.
Sofern Vitamin A, bzw. Vitamin-A-Derivate, bzw. Carotine bzw. deren Derivate das oder die Antioxidantien darstellen, ist vorteilhaft, deren jeweilige Konzentrationen aus dem Bereich von 0,001 bis 10 Gew.-%, bezogen auf das Gesamtgewicht der Formulierung, zu wählen.Provided Vitamin A, or vitamin A derivatives, or carotenes or their derivatives the one or more antioxidants are advantageous, their respective Concentrations from the range of 0.001 to 10 wt .-%, based on the total weight of the formulation to choose.
Erfindungsgemäß vorteilhaft wird die erfindungsgemäße Zubereitung durch einen Farbstoff eingefärbt. Die Farbstoffe können aus der entsprechenden Positivliste der Kosmetikverordnung bzw. der EG-Liste kosmetischer Färbemittel ausgewählt werden. In den meisten Fällen sind sie mit den für Lebensmittel zugelassenen Farbstoffen identisch. Der Gehalt an einem oder mehreren Farbstoffen ist vorteilhaft ≤ 0,05 Gew.-%, bezogen auf das Gesamtgewicht der Zubereitung. Zur Einfärbung eignen sich insbesondere öllösliche Farbstoffe.According to the invention advantageous is the preparation of the invention dyed by a dye. The Dyes can from the corresponding positive list of the Cosmetics Regulation or the EC list of cosmetic colorants selected become. In most cases are you with the for Food approved dyes identical. The content of one or more dyes is advantageously ≤ 0.05 wt .-%, based on the Total weight of the preparation. For coloring, in particular oil-soluble dyes are suitable.
Besonders bevorzugt sind erfindungsgemäße Zubereitungen und Verwendungen, welche neben den oben genannten Bestandteilen Glycerin (Propantriol) enthalten. Glycerin ist eine farblose, klare, hochviskose, geruchlose, süß schmeckende, hygroskopische, praktisch ungiftige Flüssigkeit, die mit Wasser und Alkohol in jedem Verhältnis mischbar ist. Glycerin ist in verschiedenen Reinheiten erhältlich. Es ist vorteilhaft im Sinne der vorliegenden Erfindung, wenn das Glycerin möglichst rein ist, also beispielsweise „chemisch rein" nach DAB, insbesondere auch „reinst" nach DAB.Especially Preference is given to preparations according to the invention and uses, in addition to the above ingredients Glycerol (propanetriol) included. Glycerine is a colorless, clear, high-viscosity, odorless, sweet-tasting, hygroscopic, practically non-toxic liquid containing water and Alcohol in every relationship is miscible. Glycerol is available in various purities. It is advantageous for the purposes of the present invention, if the Glycerin as possible is pure, so for example "chemically purely "after DAB, especially "pure" after DAB.
Erfindungsgemäß vorteilhaft enthalten die erfindungsgemäßen Zubereitungen Glycerin in einer Konzentration von 8 bis 20 Gewichts-%, bevorzugt in einer Konzentration von 12 bis 16 Gewichts-% , jeweils bezogen auf das Gesamtgewicht der Zubereitung.According to the invention advantageous contain the preparations according to the invention Glycerol in a concentration of 8 to 20% by weight, preferably in a concentration of 12 to 16% by weight, in each case on the total weight of the preparation.
Ferner ist es im Sinne der vorliegenden Erfindung, der erfindungsgemäßen Zubereitung Perlglanzpigmente, Schwebstoffe wie beispielsweise Glimmer, Glitterstoffe, Kügelchen und/oder Effektpigmente, Peelingpartikel, wie z. B. Polyethylen, zuzusetzen, um die Zubereitung optisch attraktiver zu gestalten und/oder einen Zusatznutzen herbeizuführen. Auch kann die erfindungsgemäße Zubereitung mit Gasblasen, insbesondere Luftblasen, oder Schlieren, insbesondere Farbschlieren, in für die Erfindung vorteilhafter Weise versehen sein.Further it is within the meaning of the present invention, the preparation of the invention Pearlescent pigments, suspended matter such as mica, glitter, globule and / or effect pigments, peeling particles, such. Polyethylene, added to make the preparation visually attractive and / or to bring about an added benefit. Also, the preparation of the invention with gas bubbles, in particular air bubbles, or streaks, in particular Color streaks, in for the invention be provided advantageously.
Erfindungsgemäß ist auch das Verfahren zur Herstellung erfindungsgemäßer Reinigungszubereitungen, welches dadurch gekennzeichnet ist, dass die öllöslichen Tenside sowie die Öle mit dem Gelbildner versetzt auf 80–90°C erhitzt und durch Rühren homogenisiert oder mit Hilfe eines Ultra-Turrax vermischt und mit Luftblasen versetzt werden und anschließend auf Raumtemperatur abgekühlt werden, wobei der Zubereitung bei 50°C unter Rühren oder mit Hilfe eines Ultra-Turrax weitere Öl- und/oder Tensid-Komponenten zugesetzt werden können.Also according to the invention the process for the production of cleaning preparations according to the invention, which is characterized in that the oil-soluble surfactants and the oils with the Gelling agent heated to 80-90 ° C heated and by stirring homogenized or mixed with the aid of an Ultra-Turrax and with air bubbles be offset and then cooled to room temperature with the preparation at 50 ° C with stirring or with the help of an Ultra-Turrax further oil and / or surfactant components can be added.
Erfindungsgemäß ist die
Verwendung von modifizierten Polyamid-Gelbildnern, welche die folgende Struktur
aufweisen:
R1 =
Kohlenwasserstoff mit 1–22
Kohlenstoffatomen,
R2 = Kohlenwasserstoff
mit 2–42
Kohlenstoffatomen,
R3 = Kohlenwasserstoff
mit 2–36
Kohlenstoffatomen, enthaltend 0–3
Heteroatome, gewählt
aus der Gruppe Sauerstoff und Stickstoff,
R3a=
N, C1-C10-Kohlenstoffrest,
zur
Erhöhung
der Viskosität
lipophiler kosmetischer Zubereitungen, sowie die Verwendung von
modifizierten Polyamid-Gelbildnern, welche die folgende Struktur
aufweisen:
R1 =
Kohlenwasserstoff mit 1–22
Kohlenstoffatomen,
R2 = Kohlenwasserstoff
mit 2–42
Kohlenstoffatomen,
R3 = Kohlenwasserstoff
mit 2–36
Kohlenstoffatomen, enthaltend 0–3
Heteroatome, gewählt
aus der Gruppe Sauerstoff und Stickstoff,
R3a
= N, C1-C10-Kohlenstoffrest,
zur
Erhöhung
der Viskosität
von Duschölen.According to the invention, the use of modified polyamide gelling agents, which have the following structure:
R 1 = hydrocarbon with 1-22 carbon atoms,
R 2 = hydrocarbon with 2-42 carbon atoms,
R 3 = hydrocarbon having 2-36 carbon atoms containing 0-3 heteroatoms selected from the group of oxygen and nitrogen,
R 3 a = N, C 1 -C 10 -carbon radical,
for increasing the viscosity of lipophilic cosmetic preparations, and the use of modified polyamide gelling agents, which have the following structure:
R 1 = hydrocarbon with 1-22 carbon atoms,
R 2 = hydrocarbon with 2-42 carbon atoms,
R 3 = hydrocarbon having 2-36 carbon atoms containing 0-3 heteroatoms selected from the group of oxygen and nitrogen,
R 3 a = N, C 1 -C 10 -carbon radical,
to increase the viscosity of shower oils.
Erfindungsgemäß bevorzugte
Ausführungsformen
der erfindungsgemäßen Verwendungen
sind dadurch gekennzeichnet, dass der oder die Polyamid-Gelbildner
als Strukturelement
Erfindungsgemäß bevorzugt wird der Baustein R2 aus einem C10-C22-Kohlenstoffrest gebildet.According to the invention, the building block R 2 is preferably formed from a C 10 -C 22 -carbon radical.
Ferner ist es erfindungsgemäß besonders bevorzugt, wenn der Baustein R2 aus einer C16H32-Alkylkette gebildet wird.Furthermore, it is particularly preferred according to the invention if the building block R 2 is formed from a C 16 H 32 -alkyl chain.
Erfindungsgemäß besonders bevorzugt ist die Verwendung der am Tage der Prioritätsanmeldung unter dem Handelsnamen Sylvaclear A200V bei der Firma Arizona Chemical frei erhältliche Verbindung mit der INCI-Bezeichnung Ethylenediamine/Hydrogenated Dimer Dilinoleate Copolymer Bis-Di-C14-18 Alkyl Amide.Particularly according to the invention preferred is the use of on the day of the priority application under the trade name Sylvaclear A200V at Arizona Chemical freely available Compound with the INCI name Ethylenediamine / Hydrogenated Dimer Dilinoleate Copolymer bis-di-C14-18 alkyl amides.
Zur Anwendung werden die kosmetischen und dermatologischen Zubereitungen in der für Kosmetika üblichen Weise auf die Haut und/oder die Haare in ausreichender Menge aufgebracht.to The cosmetic and dermatological preparations are used in the for Cosmetics usual Applied to the skin and / or hair in sufficient quantity.
Die erfindungsgemäßen Zubereitungen können vorteilhaft als Wannen(bad)zubereitungen, also beispielsweise als Ölbäder und dergleichen, aber auch als Duschpräparate – wie z. B. als Duschöle verwendet werden.The preparations according to the invention can advantageous as tub (bad) preparations, so for example as oil baths and the like, but also as shower preparations - such. B. be used as shower oils.
Die nachfolgenden Beispiele sollen die vorliegende Erfindung verdeutlichen. Die Zahlenwerte in den Beispielen bedeuten Gewichtsprozente, bezogen auf das Gesamtgewicht der Zubereitungen.The The following examples illustrate the present invention. The numerical values in the examples mean percentages by weight on the total weight of the preparations.
Beispiele
Claims (10)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2003150425 DE10350425A1 (en) | 2003-10-29 | 2003-10-29 | Viscous shower oil |
| PCT/EP2004/052712 WO2005041917A1 (en) | 2003-10-29 | 2004-10-29 | Viscous shower gel |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2003150425 DE10350425A1 (en) | 2003-10-29 | 2003-10-29 | Viscous shower oil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE10350425A1 true DE10350425A1 (en) | 2005-07-14 |
Family
ID=34529863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2003150425 Withdrawn DE10350425A1 (en) | 2003-10-29 | 2003-10-29 | Viscous shower oil |
Country Status (2)
| Country | Link |
|---|---|
| DE (1) | DE10350425A1 (en) |
| WO (1) | WO2005041917A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3130330A1 (en) | 2015-08-12 | 2017-02-15 | Beiersdorf AG | Oil based cleaning product with particulates |
| EP3130329A1 (en) | 2015-08-12 | 2017-02-15 | Beiersdorf AG | Oil based cleaning product |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7993662B2 (en) | 2005-06-14 | 2011-08-09 | Kokyu Alcohol Kogyo Co., Ltd. | Transparent solid oil cosmetics |
| FR2918563B1 (en) * | 2007-07-12 | 2009-12-04 | Oreal | AQUEOUS FLUID PHOTOPROTECTIVE COMPOSITION BASED ON A POLYAMIDE POLYMER WITH TERTIARY AMIDE TERMINATION. |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0122324A1 (en) * | 1983-04-15 | 1984-10-24 | Miranol Inc. | Polyquaternary ammonium compounds and cosmetic compositions containing them |
| FR2785799A1 (en) * | 1998-11-12 | 2000-05-19 | Oreal | COSMETIC CONDITIONING AND DETERGENT COMPOSITION COMPRISING A CARBOXYLIC SURFACTANT, A SILICONE AND A CATIONIC POLYMER, USE AND METHOD. |
| FR2785794A1 (en) * | 1998-11-12 | 2000-05-19 | Oreal | COSMETIC COMPOSITIONS CONTAINING ANIONIC ALKYLPOLYGLYCOSIDE ESTER SURFACTANT AND CATIONIC POLYMER AND USES THEREOF |
| EP1025833A1 (en) * | 1999-02-03 | 2000-08-09 | L'oreal | Detergent cosmetic compositions and their use |
| EP1025839A1 (en) * | 1999-02-03 | 2000-08-09 | L'oreal | Cosmetic composition containing an antionic and amphoteric surfactant, a polyolefin, a cationic polymer and a salt or watersoluble alcohol, use and process. |
| EP1029533A1 (en) * | 1999-02-16 | 2000-08-23 | L'oreal | Cosmetic compositions containing a hydroxyalkylether anionic surfactant and a cationic polymer, and their uses |
| US6165971A (en) * | 1998-05-20 | 2000-12-26 | Basf Aktiengesellschaft | Use of amides of polymerized fatty acids as thickeners |
| US20030069388A1 (en) * | 1999-01-04 | 2003-04-10 | Lawson Nelson E. | Tertiary amide terminated polyamides in cosmetics |
| WO2003050164A1 (en) * | 2001-12-13 | 2003-06-19 | Arizona Chemical Company | Aqueous suspensions containing polymerized fatty acid-based polyamides |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4424210C2 (en) * | 1994-07-09 | 1997-12-04 | Beiersdorf Ag | Use of compositions containing surfactants and containing oil components, which are otherwise water-free, as cosmetic or dermatological shower oils |
| DE19843547B4 (en) * | 1997-09-26 | 2007-08-02 | Sebapharma Gmbh & Co. | shower oil |
| FR2791061B1 (en) * | 1999-03-19 | 2001-08-17 | Rhodia Chimie Sa | USE OF COPOLYMERS DERIVED FROM POLYAMIDES AS GELLIFICANTS OF LOW POLAR COMPOUNDS |
-
2003
- 2003-10-29 DE DE2003150425 patent/DE10350425A1/en not_active Withdrawn
-
2004
- 2004-10-29 WO PCT/EP2004/052712 patent/WO2005041917A1/en not_active Ceased
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0122324A1 (en) * | 1983-04-15 | 1984-10-24 | Miranol Inc. | Polyquaternary ammonium compounds and cosmetic compositions containing them |
| US6165971A (en) * | 1998-05-20 | 2000-12-26 | Basf Aktiengesellschaft | Use of amides of polymerized fatty acids as thickeners |
| FR2785799A1 (en) * | 1998-11-12 | 2000-05-19 | Oreal | COSMETIC CONDITIONING AND DETERGENT COMPOSITION COMPRISING A CARBOXYLIC SURFACTANT, A SILICONE AND A CATIONIC POLYMER, USE AND METHOD. |
| FR2785794A1 (en) * | 1998-11-12 | 2000-05-19 | Oreal | COSMETIC COMPOSITIONS CONTAINING ANIONIC ALKYLPOLYGLYCOSIDE ESTER SURFACTANT AND CATIONIC POLYMER AND USES THEREOF |
| US20030069388A1 (en) * | 1999-01-04 | 2003-04-10 | Lawson Nelson E. | Tertiary amide terminated polyamides in cosmetics |
| EP1025833A1 (en) * | 1999-02-03 | 2000-08-09 | L'oreal | Detergent cosmetic compositions and their use |
| EP1025839A1 (en) * | 1999-02-03 | 2000-08-09 | L'oreal | Cosmetic composition containing an antionic and amphoteric surfactant, a polyolefin, a cationic polymer and a salt or watersoluble alcohol, use and process. |
| EP1029533A1 (en) * | 1999-02-16 | 2000-08-23 | L'oreal | Cosmetic compositions containing a hydroxyalkylether anionic surfactant and a cationic polymer, and their uses |
| WO2003050164A1 (en) * | 2001-12-13 | 2003-06-19 | Arizona Chemical Company | Aqueous suspensions containing polymerized fatty acid-based polyamides |
| US20030162938A1 (en) * | 2001-12-13 | 2003-08-28 | Arizona Chemical Company | Aqueous suspensions containing polymerized fatty acid-based polyamides |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3130330A1 (en) | 2015-08-12 | 2017-02-15 | Beiersdorf AG | Oil based cleaning product with particulates |
| EP3130329A1 (en) | 2015-08-12 | 2017-02-15 | Beiersdorf AG | Oil based cleaning product |
| DE102015215359A1 (en) | 2015-08-12 | 2017-02-16 | Beiersdorf Ag | Semi-solid cleaning product based on oil containing exfoliating particles |
| DE102015215358A1 (en) | 2015-08-12 | 2017-02-16 | Beiersdorf Ag | Semi-solid cleaning product based on oil |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005041917A1 (en) | 2005-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005030163A1 (en) | Foaming preparation with a yield point | |
| EP1114639A2 (en) | Use of a mixture of a co-surfactant and a surfactant (e.g. SLES) for the preparation of particularly skin compatible cosmetic or dermatologic cleansing compositions | |
| EP3843697B1 (en) | Mild cleaning preparation ii | |
| DE102005014423A1 (en) | Care system of PVP and acrylate polymers | |
| DE102004028629A1 (en) | Stabilization of dyes in cosmetic and dermatological preparations | |
| EP1114640A2 (en) | Method for the preparation of very skin compatible cleansing cosmetic or dermatologic compositions, containing a mixture of a co-surfactant with a surfactant (e.g. SLES) | |
| EP0870494B1 (en) | Cosmetic and dermatological washing composition containing acrylate copolymers, alkylglucosides and alcohols | |
| DE10350425A1 (en) | Viscous shower oil | |
| WO2000011124A1 (en) | Cosmetic or dermatological preparations containing n-acylamino acids or their salts | |
| DE102005033663A1 (en) | Particularly mild shower formulation | |
| DE102006011884A1 (en) | Silicone-free hair cleansing emulsion | |
| DE102010022062A1 (en) | Cosmetic body cleanser with no noticeable lack of alkoxylated surfactants | |
| EP2654694A2 (en) | Active ingredient combinations of glyceryl glucosides and one or more pearlescent agents and/or opacifiers | |
| EP1467704B1 (en) | Cosmetic cleaning agent for the hair with excellent foaming and haircare properties | |
| DE10216509A1 (en) | Free-flowing cosmetic or dermatological cleansing gel contains 12-22C fatty acid as alkali(ne earth) soap together with pre-gelatinized crosslinked starch derivative | |
| DE19814980A1 (en) | Cosmetic and dermatological compositions useful for rapid rejuvenation or maintenance of barrier function of skin | |
| EP1387666B1 (en) | Two-phase cleansing agents having a high oil content | |
| WO2005032508A1 (en) | Transparent two-phase cleaning preparations with variable viscosities | |
| DE10342418A1 (en) | Washing-active cosmetic or dermatological formulations, used for e.g. for bath and shower formulation or shampoo, contain alkyl and/or alkyl ether sulfate, anionic surfactant and ethoxylated fatty acid glycerides | |
| EP1166772A1 (en) | Cosmetic cleansing composition with a high oil concentration | |
| DE102015215358A1 (en) | Semi-solid cleaning product based on oil | |
| WO2005027860A1 (en) | Detergent-containing preparation with a combination of polysaccharide polymers and tetra-copolymers and use thereof for example for personal cleaning | |
| WO2002087539A2 (en) | TWO-PHASE CLEANING PREPARATIONS WITH HIGH OIL CONTENT | |
| DE10324788A1 (en) | Solid cosmetic purifying preparation in the form of a plate, board or rod for cleaning and caring for the skin and hair has predetermined breaking points so that defined individual pieces can be removed from the whole part | |
| DE9422474U1 (en) | Anhydrous cosmetic or dermatological shower compsn. - contg. surfactant and oil with high content of tri:glyceride(s) of fatty acids, giving good care and cleaning effect |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OM8 | Search report available as to paragraph 43 lit. 1 sentence 1 patent law | ||
| 8141 | Disposal/no request for examination |